Protalix BioTherapeutics to Participate in the 13th Annual WORLDSymposium™ 2017
Feb 13, 2017 12:01 pm UTC| Business
Data to be presented in three oral presentations and two poster presentations CARMIEL, Israel, Feb. 13, 2017 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that the Company will...
Feb 13, 2017 12:01 pm UTC| Business
GAITHERSBURG, Md., Feb. 13, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $30.5...
Feb 13, 2017 12:01 pm UTC| Business
GAITHERSBURG, Md., Feb. 13, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $30.5...
TearLab Provides Update on International Market Milestones
Feb 13, 2017 12:01 pm UTC| Business
SAN DIEGO, Feb. 13, 2017 -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) announced today the achievement of several recent milestones in the global commercialization of the TearLab Osmolarity System,...
TearLab Provides Update on International Market Milestones
Feb 13, 2017 12:01 pm UTC| Business
SAN DIEGO, Feb. 13, 2017 -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) announced today the achievement of several recent milestones in the global commercialization of the TearLab Osmolarity System,...
Feb 13, 2017 12:01 pm UTC| Business
MOORESTOWN, N.J., Feb. 13, 2017 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company providing medication safety solutions for health plans and provider groups, successfully launched, on...
Feb 13, 2017 12:01 pm UTC| Business
MOORESTOWN, N.J., Feb. 13, 2017 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company providing medication safety solutions for health plans and provider groups, successfully launched, on...